This article first appeared on GuruFocus .
-
Revenue Growth:25% growth to approximately EUR2.5 billion.
-
Dividend Increase:33% increase to EUR3.60.
-
Bond Realization:EUR860 million bonds realized to strengthen the balance sheet.
-
Corporate & Specialty Growth:10% growth with EUR551 million net income.
-
Retail International Growth:36% increase to EUR611 million net income.
-
Retail Germany Growth:6% increase in net income despite losing TARGO cooperation.
-
Return on Equity:Close to 20% for the year.
-
Large Loss Budget Usage:5.4% of net earned premiums, resulting in a EUR630 million windfall.
-
Combined Ratio:Corporate & Specialty at 90%, Reinsurance at 84%, Retail International and Retail Germany at 92%.
-
Net Asset Value Creation:EUR2.5 billion.
-
Solvency Ratio:Slightly above 240%.
-
Debt Leverage:Reduced to 29.7% for Talanx Group.
-
Investment Portfolio:80% in fixed income, 93% in investment grade.
-
Hannover Re Growth:2% growth, 13% increase in net income to EUR1.3 billion (50% share for Talanx).
-
Outlook for 2026:Net income expected to increase by 9% to around EUR2.7 billion.
Release Date: March 18, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Talanx AG ( TLLXY ) reported a record year in 2025 with a 25% growth in earnings to approximately EUR 2.5 billion.
-
The company increased its dividend by 33% to EUR 3.60, reflecting strong profitability and confidence in future performance.
-
Talanx AG ( TLLXY ) boasts a strong balance sheet, having realized EUR 860 million in bonds to enhance financial stability.
-
The company achieved a well-diversified portfolio with a 50-50 split between segments, enhancing resilience and growth potential.
-
Corporate & Specialty and Retail International segments showed significant growth, with net income increases of 10% and 36%, respectively.
Negative Points
-
The company acknowledges that the low large loss burden in 2025 was partly due to luck, and expects a return to normal levels in 2026.
-
The end of the TARGO cooperation led to a decline in insurance revenue for Retail Germany, impacting overall growth.
-
Despite strong performance, the company remains cautious about potential impacts from global warming and geopolitical tensions, such as the Middle East conflict.
-
The solvency ratio, although improved, is subject to fluctuations due to market conditions and regulatory changes.
-
Talanx AG ( TLLXY ) faces challenges in maintaining its cost advantage amid a softening market and increasing competition.
Q & A Highlights
Q: How should we think about the combined ratio for Corporate & Specialty in 2026 and beyond, and what are the levers for earnings management? A: The target for the combined ratio is maintained at better than 92%, reflecting a normalized large loss development. Regarding earnings management, the primary lever available now is through the fixed income portfolio, as the reserving side of the balance sheet has limited room for maneuver. (Torsten Leue, CEO & Jan Wicke, CFO)
Q: What are your thoughts on the situation in the Middle East and its impact on Corporate & Specialty and Reinsurance? A: It's too early to assess the full impact. Currently, there is no significant material damage in our portfolio, and we have limited exposure in Iran. The situation's impact will depend on the duration and scale of the conflict. (Torsten Leue, CEO)
Q: Can you explain the significant increase in the solvency ratio to 240%? A: The increase is due to higher own funds while the solvency capital requirement remained stable. This stability is attributed to our conservative investment portfolio and favorable interest rate and spread conditions at the end of the year. (Jan Wicke, CFO)
Q: What are your plans for the high solvency ratio, and are there any potential deals in the pipeline? A: We are open to deals, particularly in Latin America and enhancing our Corporate & Specialty portfolios. However, we maintain discipline, and only a small fraction of potential deals are realized. (Jan Wicke, CFO)
Q: How do you plan to develop the Corporate & Specialty business line, especially in North America? A: We aim to expand in North America, focusing on niche areas within the Specialty market. The U.S. is a target market, and we are actively exploring opportunities, although nothing concrete is in the pipeline yet. (Torsten Leue, CEO)
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
